Ashkan Emadi
Chair, Department of Medical Oncology, WVU School of Medicine · West Virginia University School of Medicine
Credentials: · · · · · ·
History
PresentDepartment of Medical Oncology · West Virginia University School of Medicine
- Present
Medical Oncology Division · West Virginia University School of Medicine
- Present
Medical Oncology Division · West Virginia University School of Medicine
Research
Cyclophosphamide and cancer: golden anniversary
Review · Nature Reviews Clinical Oncology · 2009 · First of 3 authors · Corresponding · 770 citations
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Blood · 2021 · 271 citations
Ruthenium-based chemotherapeutics: are they ready for prime time?
Review · Cancer Chemotherapy and Pharmacology · 2010 · 263 citations
33 papers
- VD
30 papers
- ES
15 papers
14 papers · 9 as a resident
12 papers · 3 as a resident
12 papers
11 papers
11 papers
Grants
- 2008–2026
University of Maryland Greenebaum Cancer Centersupport Grant
National Cancer Institute · P30
Project lead · $1.5M · University of Maryland Baltimore
Clinical trials
- 2026–2031
Principal investigator · Recruiting · Phase 2
West Virginia University
- 2021–2030
Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AML
Principal investigator · Active not recruiting · Phase 1
West Virginia University
- 2014–2017
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
Principal investigator · Completed · Phase 1
Ashkan Emadi
- 2019–2027
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)